Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Mast Adds New Board Member

This article was originally published in Scrip

Executive Summary

Mast Therapeutics has appointed Matthew Pauls to its board of directors. Currently Pauls is president, CEO and on the board of Strongbridge Biopharma PLC. and prior to this he was chief commercial officer of Insmed, Inc. Before this, he was senior vice-president, head of global commercial operations at Shire Pharmaceuticals. Previously, Pauls held senior positions at Bristol-Myers Squibb, in brand management and payor marketing, and at Johnson & Johnson in various US and global commercial roles.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register